Sphera Funds Management Ltd. 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Sphera Funds Management Ltd. disclosed 101 US equity positions worth $382.5m in its Q2 2025 13F filing. The largest position was TEVA at 7.1% of the reported book, followed by NVMI and SNDX. Against the Q1 2025 filing, it opened 5 new positions, added to 15 and reduced 25 among the top 50 holdings.
What did Sphera Funds Management Ltd. own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 7.1% | $27.2m | 1,620,990 | 3% | added |
| 2 | NVMI NOVA LTD | Technology | 5.5% | $20.9m | 75,836 | -16% | reduced |
| 3 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.8% | $14.7m | 1,571,564 | -6% | reduced |
| 4 | TSEM TOWER SEMICONDUCTOR LTD | Technology | 3.0% | $11.5m | 264,722 | 330% | added |
| 5 | CYTK CYTOKINETICS INC | Healthcare | 2.8% | $10.8m | 326,718 | 125% | added |
| 6 | SNY SANOFI | 2.8% | $10.6m | 219,515 | -28% | reduced | |
| 7 | BIIB BIOGEN INC | Healthcare | 2.7% | $10.4m | 82,738 | 264% | added |
| 8 | AZN ASTRAZENECA PLC | Healthcare | 2.5% | $9.4m | 135,060 | -23% | reduced |
| 9 | LLY ELI LILLY & CO | Healthcare | 2.4% | $9.0m | 11,540 | -1% | reduced |
| 10 | NVDA NVIDIA CORPORATION | Technology | 2.3% | $8.6m | 54,515 | 84% | added |
| 11 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 2.2% | $8.5m | 419,540 | -17% | reduced |
| 12 | NVO NOVO-NORDISK A S | Healthcare | 1.9% | $7.3m | 105,677 | -11% | reduced |
| 13 | AMZN AMAZON COM INC | Consumer Cyclical | 1.9% | $7.1m | 32,441 | -11% | reduced |
| 14 | CDTX CIDARA THERAPEUTICS INC | 1.8% | $6.7m | 138,001 | 706% | added | |
| 15 | ORA ORMAT TECHNOLOGIES INC | Utilities | 1.7% | $6.5m | 78,000 | -7% | reduced |
| 16 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.7% | $6.5m | 480,974 | 3% | added |
| 17 | FBRX FORTE BIOSCIENCES INC | 1.7% | $6.4m | 495,109 | – | new | |
| 18 | META META PLATFORMS INC | Communication Services | 1.6% | $6.3m | 8,526 | -14% | reduced |
| 19 | JNJ JOHNSON & JOHNSON | Healthcare | 1.6% | $6.2m | 40,831 | -23% | reduced |
| 20 | MSFT MICROSOFT CORP | Technology | 1.5% | $5.9m | 11,792 | 157% | added |
| 21 | AM6 AMICUS THERAPEUTICS INC | 1.5% | $5.7m | 990,718 | – | new | |
| 22 | ORMAT TECHNOLOGIES INC | 1.5% | $5.6m | 5,037,000 | 0% | held | |
| 23 | PHVS PHARVARIS N V | 1.4% | $5.5m | 309,931 | -19% | reduced | |
| 24 | ELDN ELEDON PHARMACEUTICALS INC | 1.4% | $5.3m | 1,959,610 | -15% | reduced | |
| 25 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.3% | $5.0m | 335,333 | 68% | added |
| 26 | ABBV ABBVIE INC | Healthcare | 1.2% | $4.7m | 25,256 | -17% | reduced |
| 27 | GSK GSK PLC | Healthcare | 1.2% | $4.7m | 122,000 | -6% | reduced |
| 28 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.2% | $4.6m | 109,757 | -22% | reduced |
| 29 | NVS NOVARTIS AG | Healthcare | 1.2% | $4.5m | 37,000 | -26% | reduced |
| 30 | TRVI TREVI THERAPEUTICS INC | Healthcare | 1.1% | $4.4m | 799,957 | – | new |
| 31 | MAZE MAZE THERAPEUTICS INC | 1.1% | $4.4m | 356,453 | 0% | held | |
| 32 | ANNX ANNEXON INC | Healthcare | 1.1% | $4.2m | 1,764,387 | 0% | held |
| 33 | IMVT IMMUNOVANT INC | Healthcare | 1.1% | $4.1m | 256,743 | 32% | added |
| 34 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.0% | $4.0m | 394,693 | 68% | added |
| 35 | MRK MERCK & CO INC | Healthcare | 1.0% | $3.8m | 48,600 | -18% | reduced |
| 36 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 1.0% | $3.8m | 174,900 | – | new |
| 37 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.0% | $3.8m | 87,108 | -76% | reduced |
| 38 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.0% | $3.6m | 100,085 | -63% | reduced |
| 39 | RNAGBP AVIDITY BIOSCIENCES INC | 0.9% | $3.6m | 126,000 | 19% | added | |
| 40 | ALPHA COGNITION INC | 0.9% | $3.5m | 376,649 | -37% | reduced | |
| 41 | RZLT REZOLUTE INC | 0.9% | $3.4m | 751,447 | -31% | reduced | |
| 42 | HELP CYBIN INC | 0.9% | $3.3m | 398,309 | -24% | reduced | |
| 43 | AMAT APPLIED MATLS INC | Technology | 0.9% | $3.3m | 18,000 | 0% | held |
| 44 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 0.8% | $3.2m | 202,996 | -27% | reduced |
| 45 | IMTX IMMATICS N.V | Healthcare | 0.8% | $3.1m | 583,105 | -37% | reduced |
| 46 | SVRA SAVARA INC | Healthcare | 0.8% | $3.0m | 1,310,233 | 2% | added |
| 47 | UBER UBER TECHNOLOGIES INC | Technology | 0.7% | $2.8m | 30,000 | 0% | held |
| 48 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.7% | $2.7m | 159,323 | 1% | added |
| 49 | CAMT CAMTEK LTD | Technology | 0.7% | $2.7m | 31,976 | 39% | added |
| 50 | ELBIT SYS LTD | 0.7% | $2.7m | 6,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.